Kolexia
Leboulleux Sophie Médecine nucléaire
Leboulleux Sophie
Médecine nucléaire
Gustave-Roussy
Villejuif, France
321 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs de la thyroïde Carcinomes Métastase tumorale Cancer papillaire de la thyroïde Maladies de la thyroïde Carcinome corticosurrénalien Carcinome neuroendocrine Adénocarcinome folliculaire Carcinome papillaire

Collaborateurs

Voir plus
Schlumberger Martin
Schlumberger Martin
Gustave-Roussy, Villejuif, France
Baudin Eric
Baudin Eric
Gustave-Roussy, Villejuif, France
Al Ghuzlan Abir
Al Ghuzlan Abir
Gustave-Roussy, Villejuif, France
Deandreis Desiree
Deandreis Desiree
Gustave-Roussy, Villejuif, France

Industries

Voir plus
Lilly
6 collaboration(s)
Dernière en 2020
Eisai
3 collaboration(s)
Dernière en 2021
Bayer
3 collaboration(s)
Dernière en 2021
Ipsen
1 collaboration(s)
Dernière en 2022

Dernières activités

Voir plus
LIBRETTO-001: A Phase 1/2 Study of Oral Selpercatinib (LOXO-292) in Patients With Advanced Solid Tumors, Including RET Fusion-Positive Solid Tumors, Medullary Thyroid Cancer, and Other Tumors With RET Activation (LIBRETTO-001)
Essai Clinique (Loxo Oncology, Inc.)   01 mars 2024
Assessment of the risk of malignancy in Bethesda III thyroid nodules: a comprehensive review.
Endocrine   28 février 2024
ARROW: A Phase 1/2 Study of the Highly-selective RET Inhibitor, BLU-667, in Patients With Thyroid Cancer, Non-Small Cell Lung Cancer (NSCLC) and Other Advanced Solid Tumors
Essai Clinique (Roche)   21 février 2024
Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†.
Annals of oncology : official journal of the European Society for Medical Oncology   13 novembre 2023
Long term activity of vemurafenib in cancers with BRAF mutations: the ACSE basket study for advanced cancers other than BRAF -mutated melanoma.
ESMO open   01 novembre 2023
Unnecessary thyroid surgery rate for suspicious nodule in the absence of molecular testing.
European thyroid journal   11 octobre 2023
Estimabl2 trial: Thyroidectomy without radioiodine in patients with low-risk thyroid cancer, 5 years of follow-up
39e congrès de la Société Française d'Endocrinologie 2023   01 octobre 2023
Skeletal related events in differentiated thyroid cancer with bone metastasis: A bicentric study
39e congrès de la Société Française d'Endocrinologie 2023   01 octobre 2023
Use of lenvatinib in the treatment of radioiodine-refractory differentiated thyroid cancer: a multidisciplinary perspective for daily practice.
European thyroid journal   08 août 2023
MERAIODE: A Phase II Redifferentiation Trial with Trametinib and I in Metastatic Radioactive Iodine Refractory Mutated Differentiated Thyroid Cancer.
Thyroid : official journal of the American Thyroid Association   26 juillet 2023